• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-甘油磷酸胆碱和泛醇滴眼液用于白内障手术患者。

Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery.

作者信息

Martone Gianluca, Balestrazzi Alessandra, Ciprandi Giorgio, Balestrazzi Angelo

机构信息

UOC Oculistica, Usl Sud-Est Toscana, Grosseto, Italy.

UOC Oculistica, ASL ROMA 2, Rome, Italy.

出版信息

J Ophthalmol. 2022 Jun 7;2022:1951014. doi: 10.1155/2022/1951014. eCollection 2022.

DOI:10.1155/2022/1951014
PMID:35711284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9197661/
Abstract

Cataract surgery is widespread. The surgical procedure is associated with damage to the epithelial barrier and interruption of the corneal innervation. In addition, pathological events sustain signs and symptoms that may persist for a long time. Recently, a fixed combination of alpha-glycerylphosphorylcholine and D-Panthenol (Oftassiale) has been available as eye drops. The present study investigated the effects of an Oftassiale therapy in 20 patients undergoing cataract surgery. A comparison group included 20 patients treated with topical hyaluronic acid. Standard prophylactic and anti-inflammatory treatment was prescribed to all patients. Clinical signs and symptoms were assessed over time. In vivo confocal microscopy (IVCM) was performed accordingly. Oftassiale treatment significantly reduced clinical features and improved IVCM outcomes. In addition, therapy was well-tolerated, and no clinically significant adverse events occurred. In conclusion, this study confirmed that IVCM helps assess the tunnel after cataract surgery due to its ability to provide microscopic details in vivo. Topical therapy with alpha-glycerylphosphorylcholine and D-Panthenol eye drops promoted and stabilized the reepithelialization process. This fixed combination also accelerated and modulated the repair of the corneal innervation. Moreover, this treatment was well-tolerated and safe.

摘要

白内障手术很普遍。该手术过程会对上皮屏障造成损害并中断角膜神经支配。此外,病理事件会导致一些可能长期持续的体征和症状。最近,α-甘油磷酸胆碱和D-泛醇的固定组合(Oftassiale)已作为眼药水上市。本研究调查了Oftassiale疗法对20例接受白内障手术患者的影响。一个对照组包括20例接受局部透明质酸治疗的患者。所有患者均接受标准的预防性和抗炎治疗。随时间评估临床体征和症状。相应地进行了体内共聚焦显微镜检查(IVCM)。Oftassiale治疗显著减轻了临床症状并改善了IVCM结果。此外,该疗法耐受性良好,未发生具有临床意义的不良事件。总之,本研究证实,IVCM因其能够在体内提供微观细节,有助于评估白内障手术后的切口隧道。局部使用α-甘油磷酸胆碱和D-泛醇眼药水可促进并稳定角膜上皮再形成过程。这种固定组合还加速并调节了角膜神经支配的修复。此外,该治疗耐受性良好且安全。

相似文献

1
Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery.α-甘油磷酸胆碱和泛醇滴眼液用于白内障手术患者。
J Ophthalmol. 2022 Jun 7;2022:1951014. doi: 10.1155/2022/1951014. eCollection 2022.
2
In vivo and ex vivo evaluation of cell-cell interactions, adhesion and migration in ocular surface of patients undergone excimer laser refractive surgery after topical therapy with different lubricant eyedrops.在接受准分子激光屈光手术的患者眼表,使用不同润滑眼药水进行局部治疗后,对细胞间相互作用、黏附和迁移进行体内和体外评估。
Int Ophthalmol. 2018 Aug;38(4):1591-1599. doi: 10.1007/s10792-017-0627-y. Epub 2017 Jul 4.
3
State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.N-乙酰肌肽二肽眼用前药的临床疗效与安全性评估现状。在一组威胁视力的眼部疾病的治疗和治疗管理中,关于其递送、自生物激活、分子靶点以及与高度进化的组氨酸酰肼结构相互作用的原理。
Curr Clin Pharmacol. 2009 Jan;4(1):4-37. doi: 10.2174/157488409787236074.
4
Effect of D-Panthenol on Corneal Epithelial Healing after Surface Laser Ablation.泛醇对表面激光消融术后角膜上皮愈合的影响。
J Ophthalmol. 2018 Nov 12;2018:6537413. doi: 10.1155/2018/6537413. eCollection 2018.
5
N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.N-乙酰基肉碱持续药物递送眼药水控制不老视力的迹象:眩光敏感性,白内障改善和视觉质量目前针对 50000 名患者人群的挑战性治疗方法。
Clin Interv Aging. 2009;4:31-50. Epub 2009 May 14.
6
Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study.比较托百士地塞米松滴眼液与托百士/载体滴眼液控制白内障患者术后炎症的预防效果:前瞻性、随机、双盲、双臂、平行组、安慰剂对照、多中心研究。
Clin Drug Investig. 2004;24(9):523-33. doi: 10.2165/00044011-200424090-00003.
7
Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders.海藻糖/透明质酸钠滴眼液治疗白内障术后眼表疾病。
Int Ophthalmol. 2021 Sep;41(9):3065-3071. doi: 10.1007/s10792-021-01869-z. Epub 2021 May 6.
8
Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.医疗保险受益人群行白内障手术后眼用滴剂的使用模式和费用。
Ophthalmology. 2020 May;127(5):573-581. doi: 10.1016/j.ophtha.2019.11.005. Epub 2019 Nov 14.
9
Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms.白内障手术后的干眼和眼表炎症:基于海藻糖/透明质酸的泪膜替代物与透明质酸相比在缓解体征和症状方面的有效性。
J Cataract Refract Surg. 2021 Nov 1;47(11):1430-1435. doi: 10.1097/j.jcrs.0000000000000652.
10
Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.眼表 100%血清滴眼剂治疗眼部手术后的角膜上皮缺损。
Biomed Res Int. 2013;2013:521315. doi: 10.1155/2013/521315. Epub 2013 Jul 30.

引用本文的文献

1
Choline supplements: An update.胆碱补充剂:更新。
Front Endocrinol (Lausanne). 2023 Mar 7;14:1148166. doi: 10.3389/fendo.2023.1148166. eCollection 2023.

本文引用的文献

1
Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms.白内障手术后的干眼和眼表炎症:基于海藻糖/透明质酸的泪膜替代物与透明质酸相比在缓解体征和症状方面的有效性。
J Cataract Refract Surg. 2021 Nov 1;47(11):1430-1435. doi: 10.1097/j.jcrs.0000000000000652.
2
Dry Eye and Phacoemulsification Cataract Surgery: A Systematic Review and Meta-Analysis.干眼与白内障超声乳化手术:一项系统评价与荟萃分析
Front Med (Lausanne). 2021 Jul 8;8:649030. doi: 10.3389/fmed.2021.649030. eCollection 2021.
3
The cold eye irrigation BSS solution used during phacoemulsification reduces post-surgery patients discomfort preventing the inflammation.
白内障超声乳化手术中使用的冷眼灌注平衡盐溶液可减轻术后患者的不适,预防炎症。
Eur J Ophthalmol. 2021 May 20:11206721211018377. doi: 10.1177/11206721211018377.
4
Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders.海藻糖/透明质酸钠滴眼液治疗白内障术后眼表疾病。
Int Ophthalmol. 2021 Sep;41(9):3065-3071. doi: 10.1007/s10792-021-01869-z. Epub 2021 May 6.
5
Role of Choline in Ocular Diseases.胆碱在眼部疾病中的作用。
Int J Mol Sci. 2021 Apr 29;22(9):4733. doi: 10.3390/ijms22094733.
6
Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review.医源性干眼疾病:应对白内障术后不适的难题。一篇P.I.C.A.S.S.O.委员会叙述性综述。
Ophthalmol Ther. 2021 Jun;10(2):211-223. doi: 10.1007/s40123-021-00332-7. Epub 2021 Feb 8.
7
Cataract Surgery Destabilises Temporary the Tear Film of the Ocular Surface.白内障手术会暂时破坏眼表面的泪膜稳定性。
Klin Monbl Augenheilkd. 2021 Mar;238(3):282-287. doi: 10.1055/a-1179-0373. Epub 2020 Jul 13.
8
Effects of cataract surgery on symptoms and findings of dry eye in subjects with and without preexisting dry eye.白内障手术对伴有和不伴有潜在干眼症的患者干眼症状和体征的影响。
Jpn J Ophthalmol. 2020 Jul;64(4):429-436. doi: 10.1007/s10384-020-00744-1. Epub 2020 Jun 3.
9
Short-term changes in ocular surface signs and symptoms after phacoemulsification.白内障超声乳化术后眼表体征和症状的短期变化。
Eur J Ophthalmol. 2020 Nov;30(6):1301-1307. doi: 10.1177/1120672119896427. Epub 2020 Jan 5.
10
Association among Blink Rate, Changes in Ocular Surface Temperature, Tear Film Stability, and Functional Visual Acuity in Patients after Cataract Surgery.白内障手术后患者眨眼频率、眼表温度变化、泪膜稳定性与功能性视力之间的关联。
J Ophthalmol. 2019 Aug 19;2019:8189097. doi: 10.1155/2019/8189097. eCollection 2019.